Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportRadiopharmaceutical Chemistry: Dosimetry/ISRTRD Alpha Symposium

Determination of kidney dose distributions using autoradiography and HpGe spectroscopy of kidney after injection of 225Ac-HuM195

Jazmin Schwartz, J, Jaspreet, S. Ruan, S.M. Larson, D. Scheinberg and J.L. Humm
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 37;
Jazmin Schwartz
1MSKCC, NY, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J, Jaspreet
2Pfizer, New London, CT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Ruan
1MSKCC, NY, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S.M. Larson
1MSKCC, NY, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. Scheinberg
1MSKCC, NY, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J.L. Humm
1MSKCC, NY, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

37

Objectives A major concern of using 225AcHuM195 is renal toxicity from the 3 α-emitting daughters released from the decay of 225Ac. We determined the dose distribution of 225Ac and its daughters in kidney after administration 225AcHuM195 antibody.

Methods Mice injected with 600 nCi of 225AcHuM195 antibody were sacrificed at 24,96,and 144hr.The kidneys were removed immediately. Ten sections were collected from one kidney from each animal and imaged by digital autoradiography(DAG). Exposures (EXP) were performed immediately after the sectioning (EXP 1hr), and 24hr after sectioning (EXP 16-30hr). The 1st image shows total activity distribution mainly from the daughters that translocate there. By the start of 2nd EXP all daughters had decayed,and the 225Ac parent was in equilibrium with the newly generated daughters,which remained at the parent's location. A HpGe detector was used to resolve 225Ac activity contribution from that of its daughters by measuring emitted γ's (218 & 440keV) in the second kidney.Known activity standards were measured by DAG and spectroscopy.

Results DAG images and spectra from the HpGe were calibrated with the respective standards.The dose to the cortex was calculated using the DAG as 27.3Gy from 225Ac and 4.6Gy from 213Bi and for the medulla were 17Gy (225Ac) and 6.5Gy (213Bi). The WK doses from the spectroscopy were determined to be 17.4Gy (225Ac) and 8.7Gy (213Bi).

Conclusions Doses from 225AcHUM195 and its daughters were estimated for different regions of the kidney and found to be highly tissue-dependent, and not easily determined from average dose calculations over the kidney as a whole.

  • © 2009 by Society of Nuclear Medicine
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 50, Issue supplement 2
May 2009
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Determination of kidney dose distributions using autoradiography and HpGe spectroscopy of kidney after injection of 225Ac-HuM195
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Determination of kidney dose distributions using autoradiography and HpGe spectroscopy of kidney after injection of 225Ac-HuM195
Jazmin Schwartz, J, Jaspreet , S. Ruan, S.M. Larson, D. Scheinberg, J.L. Humm
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 37;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Determination of kidney dose distributions using autoradiography and HpGe spectroscopy of kidney after injection of 225Ac-HuM195
Jazmin Schwartz, J, Jaspreet , S. Ruan, S.M. Larson, D. Scheinberg, J.L. Humm
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 37;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Radiopharmaceutical Chemistry: Dosimetry/ISRTRD Alpha Symposium

  • Radiation risk caused by [F18]BAY 94-9172, a new PET tracer for detection of cerebral β-amyloid plaques
  • Human dosimetry of the PET radioligand [C-11]flumazenil (FMZ)
  • Radiobiological effects of external and internal radiation applied on papillary thyroid carcinoma cells using an in-vitro cell model
Show more Radiopharmaceutical Chemistry: Dosimetry/ISRTRD Alpha Symposium

ISRTRD/ALPHA Session1: Clinical & Pre-clinical Studies

  • An astatine-211 labeled PSMA inhibitor for targeted alpha-particle radiotherapy of prostate carcinoma
  • Radioimmunotherapy of human bladder cancer in a nude mouse model comparing Bi-213-anti-EGFR-MAb and Th-226-anti-EGFR-MAb
Show more ISRTRD/ALPHA Session1: Clinical & Pre-clinical Studies

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire